1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.2.4 Packaging
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology Industry
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CMO Services Market Perspective (2017-2028)
2.2 Pharmaceutical CMO Services Growth Trends by Region
2.2.1 Pharmaceutical CMO Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmaceutical CMO Services Historic Market Size by Region (2017-2022)
2.2.3 Pharmaceutical CMO Services Forecasted Market Size by Region (2023-2028)
2.3 Pharmaceutical CMO Services Market Dynamics
2.3.1 Pharmaceutical CMO Services Industry Trends
2.3.2 Pharmaceutical CMO Services Market Drivers
2.3.3 Pharmaceutical CMO Services Market Challenges
2.3.4 Pharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CMO Services Players by Revenue (2017-2022)
3.1.2 Global Pharmaceutical CMO Services Revenue Market Share by Players (2017-2022)
3.2 Global Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CMO Services Revenue
3.4 Global Pharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO Services Revenue in 2021
3.5 Pharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CMO Services Historic Market Size by Type (2017-2022)
4.2 Global Pharmaceutical CMO Services Forecasted Market Size by Type (2023-2028)
5 Pharmaceutical CMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2017-2022)
5.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmaceutical CMO Services Market Size (2017-2028)
6.2 North America Pharmaceutical CMO Services Market Size by Type
6.2.1 North America Pharmaceutical CMO Services Market Size by Type (2017-2022)
6.2.2 North America Pharmaceutical CMO Services Market Size by Type (2023-2028)
6.2.3 North America Pharmaceutical CMO Services Market Share by Type (2017-2028)
6.3 North America Pharmaceutical CMO Services Market Size by Application
6.3.1 North America Pharmaceutical CMO Services Market Size by Application (2017-2022)
6.3.2 North America Pharmaceutical CMO Services Market Size by Application (2023-2028)
6.3.3 North America Pharmaceutical CMO Services Market Share by Application (2017-2028)
6.4 North America Pharmaceutical CMO Services Market Size by Country
6.4.1 North America Pharmaceutical CMO Services Market Size by Country (2017-2022)
6.4.2 North America Pharmaceutical CMO Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Market Size (2017-2028)
7.2 Europe Pharmaceutical CMO Services Market Size by Type
7.2.1 Europe Pharmaceutical CMO Services Market Size by Type (2017-2022)
7.2.2 Europe Pharmaceutical CMO Services Market Size by Type (2023-2028)
7.2.3 Europe Pharmaceutical CMO Services Market Share by Type (2017-2028)
7.3 Europe Pharmaceutical CMO Services Market Size by Application
7.3.1 Europe Pharmaceutical CMO Services Market Size by Application (2017-2022)
7.3.2 Europe Pharmaceutical CMO Services Market Size by Application (2023-2028)
7.3.3 Europe Pharmaceutical CMO Services Market Share by Application (2017-2028)
7.4 Europe Pharmaceutical CMO Services Market Size by Country
7.4.1 Europe Pharmaceutical CMO Services Market Size by Country (2017-2022)
7.4.2 Europe Pharmaceutical CMO Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO Services Market Size (2017-2028)
8.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmaceutical CMO Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmaceutical CMO Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmaceutical CMO Services Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Market Size (2017-2028)
9.2 Latin America Pharmaceutical CMO Services Market Size by Type
9.2.1 Latin America Pharmaceutical CMO Services Market Size by Type (2017-2022)
9.2.2 Latin America Pharmaceutical CMO Services Market Size by Type (2023-2028)
9.2.3 Latin America Pharmaceutical CMO Services Market Share by Type (2017-2028)
9.3 Latin America Pharmaceutical CMO Services Market Size by Application
9.3.1 Latin America Pharmaceutical CMO Services Market Size by Application (2017-2022)
9.3.2 Latin America Pharmaceutical CMO Services Market Size by Application (2023-2028)
9.3.3 Latin America Pharmaceutical CMO Services Market Share by Application (2017-2028)
9.4 Latin America Pharmaceutical CMO Services Market Size by Country
9.4.1 Latin America Pharmaceutical CMO Services Market Size by Country (2017-2022)
9.4.2 Latin America Pharmaceutical CMO Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO Services Market Size (2017-2028)
10.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmaceutical CMO Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmaceutical CMO Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmaceutical CMO Services Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.4 AGC Chemicals
11.4.1 AGC Chemicals Company Details
11.4.2 AGC Chemicals Business Overview
11.4.3 AGC Chemicals Pharmaceutical CMO Services Introduction
11.4.4 AGC Chemicals Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.4.5 AGC Chemicals Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceutical CMO Services Introduction
11.5.4 AbbVie Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.5.5 AbbVie Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Pharmaceutical CMO Services Introduction
11.6.4 Pfizer Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Evonik Health Care
11.7.1 Evonik Health Care Company Details
11.7.2 Evonik Health Care Business Overview
11.7.3 Evonik Health Care Pharmaceutical CMO Services Introduction
11.7.4 Evonik Health Care Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.7.5 Evonik Health Care Recent Developments
11.8 Delpharm
11.8.1 Delpharm Company Details
11.8.2 Delpharm Business Overview
11.8.3 Delpharm Pharmaceutical CMO Services Introduction
11.8.4 Delpharm Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.8.5 Delpharm Recent Developments
11.9 Recipharm
11.9.1 Recipharm Company Details
11.9.2 Recipharm Business Overview
11.9.3 Recipharm Pharmaceutical CMO Services Introduction
11.9.4 Recipharm Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.9.5 Recipharm Recent Developments
11.10 Teva API
11.10.1 Teva API Company Details
11.10.2 Teva API Business Overview
11.10.3 Teva API Pharmaceutical CMO Services Introduction
11.10.4 Teva API Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.10.5 Teva API Recent Developments
11.11 Catalent
11.11.1 Catalent Company Details
11.11.2 Catalent Business Overview
11.11.3 Catalent Pharmaceutical CMO Services Introduction
11.11.4 Catalent Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.11.5 Catalent Recent Developments
11.12 Esteve Quimica
11.12.1 Esteve Quimica Company Details
11.12.2 Esteve Quimica Business Overview
11.12.3 Esteve Quimica Pharmaceutical CMO Services Introduction
11.12.4 Esteve Quimica Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.12.5 Esteve Quimica Recent Developments
11.13 Fareva
11.13.1 Fareva Company Details
11.13.2 Fareva Business Overview
11.13.3 Fareva Pharmaceutical CMO Services Introduction
11.13.4 Fareva Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.13.5 Fareva Recent Developments
11.14 Patheon
11.14.1 Patheon Company Details
11.14.2 Patheon Business Overview
11.14.3 Patheon Pharmaceutical CMO Services Introduction
11.14.4 Patheon Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.14.5 Patheon Recent Developments
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.15.5 Piramal Recent Developments
11.16 Hisun Pharmaceuticals
11.16.1 Hisun Pharmaceuticals Company Details
11.16.2 Hisun Pharmaceuticals Business Overview
11.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Introduction
11.16.4 Hisun Pharmaceuticals Revenue in Pharmaceutical CMO Services Business (2017-2022)
11.16.5 Hisun Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
